
Keywords: CFA; complete Freunds adjuvant; EAE; experimental autoimmune encephalomyelitis; MOG; Myelin Oligodendroglial Protein; TEMPOL; 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl; EAE; Multiple sclerosis; Nitroxide; Inflammation; Neurodegeneration;